Impact of redo ablation for atrial fibrillation on patient-reported outcomes and quality of life.
Medhat FarwatiMustapha AminWalid I SalibaHiroshi NakagawaKhaldoun G TarakjiMohamed DiabAnna ScandinaroRuth MaddenPatricia BouscherShunsuke KurodaMohamed KanjThomas J DresingThomas D CallahanMandeep BhargavaJakub SroubekBryan BaranowskiJohn Jack RickardDaniel J CantillonPatrick J TchouOussama M WazniAyman A HusseinPublished in: Journal of cardiovascular electrophysiology (2022)
Most patients derive significant QoL benefit from redo AF ablation; with reduction of both AF burden and healthcare utilization.
Keyphrases
- patient reported outcomes
- atrial fibrillation
- catheter ablation
- healthcare
- end stage renal disease
- newly diagnosed
- left atrial
- chronic kidney disease
- oral anticoagulants
- left atrial appendage
- prognostic factors
- direct oral anticoagulants
- percutaneous coronary intervention
- mitral valve
- venous thromboembolism
- transcatheter aortic valve replacement
- health insurance
- affordable care act